Attached files
file | filename |
---|---|
10-Q - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | f10q0311v7clean.htm |
EX-31 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | exh310311.htm |
EX-10.2 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | promissarynote401converted.htm |
EX-10.1 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | promissarynoterobbinsconvert.htm |
EX-10.3 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | promissarynotetunkeyconverte.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of BioMedical Technology Solutions Holdings, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Gex F. Richardson, President/Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
/s/ Gex F. Richardson_____
Gex F. Richardson
President/Director
May 16, 2011